abstract |
The present invention relates to a novel polymorph form IV of N-[(R) -2,3-dihydroxy-propoxy] -3,4-difluoro-2- (2-fluoro-4-iodo-phenylamino) -benzamide, and Methods for producing the polymorph, and pharmaceutical compositions and treatment methods utilizing the polymorph are provided. |